Stock ACHL ACHILLES THERAPEUTICS PLC
Add to a list
To use this feature you must be a member
Log inSign up

Revisions Achilles Therapeutics plc

Equities

ACHL

US00449L1026

Delayed Nasdaq
Other stock markets
 16:00:08 29/04/2024 BST 		5-day change 1st Jan Change
0.7501 USD -1.30% Intraday chart for Achilles Therapeutics plc -5.05% -15.62%
04-05 Piper Sandler Downgrades Achilles Therapeutics to Neutral From Overweight, Cuts Price Target to $2 From $8 MT
04-05 Chardan Capital Adjusts Achilles Therapeutics Price Target to $6 From $11, Maintains Buy Rating MT

Turnover - Change in analysts' estimates

Earnings Per Share (EPS) - Change in analysts' estimates

EBIT - Change in analysts' estimates

Dividend / Share (DPS) - Change in analysts' estimates

Turnover

Earnings Per Share (EPS)

EBIT

Dividend / Share (DPS)

  1. Stock Market
  2. Equities
  3. ACHL Stock
  4. Revisions Achilles Therapeutics plc